News
6d
Zacks.com on MSNShould You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?GE HealthCare Technologies Inc. GEHC is scheduled to report second-quarter 2025 results on July 30, before market open. In ...
3d
New Scientist on MSNVagus nerve stimulation receives US approval to treat arthritisThe US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...
The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.
Shares of CVS Health jumped Thursday after the health care giant posted better-than-expected second-quarter results and ...
The scientists found that the approach of an infectious avatar fired up brain areas linked to personal space — the region ...
From, who joins the surgical robot developer from Aruna Bio, will take the reins from co-founder Adam Sachs on Aug. 7.
Vein disease is more than just a cosmetic concern. It is a widespread medical condition that can significantly affect quality ...
Understanding today’s corporatization of U.S. health care requires seeing it from a historical perspective, as a process that began with a change in the business model of care delivery in the 1920s.
Panelists discuss how patient-reported outcomes are crucial for capturing MS symptoms like fatigue, depression, and cognitive decline that significantly impact working-age patients but require ...
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Bioventus (Nasdaq:BVS) announced today that it received FDA 510(k) clearance for both its TalisMann and StimTrial offerings.
IN AND OUT Transfer news LIVE: Liverpool ‘AGREE’ terms with Isak, Luis Diaz set for Bayern medical TODAY, Everton eye Grealish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results